Conagenin (CNG), a low molecular immunomodulator, enhanced incorporation of
Immunomodulation is now an important therapeutic strategy for treatment of immunodeficient diseases such as cancer, transplantation and other immunological disorders. Most immunomodulators like MDP1}, ubenimex2) and forphenicinol3 '4) act primarily on macrophages and consequently stimulate T cells. However, it is knownthat macrophageactivation enhances inflammatory responses which frequently downregulates diseases. Thus, we have attempted to search for an immunomodulatorexhibiting specific action on T cells in microbial products and found conagenin (CNG). CNGwas isolated from cultured broth of Streptomyces roseosporus as an immunomodulator which enhances [3H]thymidine incorporation of T cells activated by concanavalin A (Con A)5). In this study, we investigated the effects of CNGon [3H]thymidine incorporation into T cells and their lymphokine production.
Materials and Methods

Mice
CDFi mice (6 weeks old, female) were purchased from Charles River Japan Inc. (Kanagawa, Japan) and were maintained under specific pathogen-free conditions at 23 ±2°C and 55 + 5% humidity. They were employed for experiments at 9 to ll weeks of age.
CNG
CNGwas prepared by KANEKA Co., Ltd. (Osaka, Japan), according to the methods reported previously5), and dissolved in culture medium and saline.
Cell Preparation
Murine spleen cells passed through a nylon wool column (WakoChemical Co. Ltd., Tokyo, Japan) were used as T cells. In the following experiments in vitro, non-activated T cells (NATC)and Con A-activated T cells (CATC) were employed. CATCwere prepared as follows; T cells (5 x 106cells/ml in RPMI 1640 (Nissui Seiyaku Co. Ltd., Tokyo, Japan) containing 10% heat inactivated fetal calf serum) were incubated with Con A (2 /jg/ml: Pharmacia Fine Chemical Inc., Uppsala, Sweden) at 37°C in 5% CO2 for 4 hours and were washed thoroughly with a-methyl mannoside (20 mg/ml : Sigma, St. Louis, U.S.A.).
To obtain macrophages, peritoneal exudate cells (PEC) were collected from mice and 1 ml of PECat 1 x 106cells/ml in RPMI1640 were plated, then incubated at 37°C in 5% CO2for 1 hour. After washing with RPMI1640, adherent cells (4~5 x 105 cells/plate) on the bottom of the plate were used as macrophages.
Assay for Incorporation of [3H]Thymidine into T Cells NATCand CATCwere treated with CNGat 37°C in 5% CO2 for 4hours. After washing with RPMI1640 thoroughly, these cells were suspended at 2.5 x 106 cells/ml in RPMI1640 supplemented with 10% heat inactivated fetal calf serum, 50^m 2-mercaptoethanol, non-essential amino acids, l mMsodium pyruvate, 50units/ml penicillin and 50^g/ml streptomycin, and were put in wells of a microplate (0.2 ml/well) and cultured for 3 days. Eighteen hours before termination of culture, [3H]thymidine ([3H]TdR : [6-3H]thymidine, sp. act. 555GBq/mmol, NET-355, New England Neuclear, Boston, U.S.A.) was added (7.4 KBq/well) and its incorporation into cultured cells was counted by a liquid scintillation counter. Triplicate cultures were madefor each determination.
Assays for Cytokine Activities CATCor NATC(5 x 106cells/ml) were treated with CNGfor 4hours and were cultured at 37°C in 5% CO2for 3 days. After incubation, the culture supernatants were collected and stored at -80°C until assay.
In order to determine effects of CNGon monokine production by macrophages, adherent PECon the plates were treated with CNGat 37°C in 5% CO2 for 4hours. After washing, PEC were cultured for 1 day, the culture supernatants were collected and stored at -80°C until assay.
The cytokine activities in the culture supernatants were measured by incorporation of [3H]TdR into cultured cytokine dependent cell lines. D10.G4.16), CTLL-27) and IC-28) cells were used as target cells. The target cells (1 x 104cells/well) were cultured with 100/xl of the T cell culture supernatants at 37°C in 5% CO2 for 3days for D10.G4.1. cell cultures or 2 days for CTLL-2 and IC-2 cell cultures. The cultured cells were pulsed with [3H]TdR (7.4 KBq/well), 18 hours before assay, and the incorporation of radioactivity into cells was counted by a liquid scintillation counter. Triplicate cultures were madefor each determination.
Effect of CNGin Mice CNGat 5mg/kg was given ip to mice, splenic T cells and adherent PEC were prepared as described above from mice on days 1 to 7 after administration. T cells and adherent PEC were cultured at 37°C in 5% CO2 for 3 days or 1day, respectively.
[3H]TdR incorporation into and lymphokine production ofT cells and monokine production of PEC were determined. Five mice were used for an assay. On the other hand, the addition of CNGfor 3 consecutive days to lymphocyte cultures containing Con A or LPS did not enhance mitogenic activity of these lectins. Next, the effect of CNGon lymphokine production was investigated. CATCor NATCwere treated with CNGfor 4hours and cultured for 3 days. As shown in Fig. 2 , the supernatants taken from CATC treated with CNGenhanced the incorporation of [3H]TdR into CTLL-2 cells at 0.1 to 1 jag/ml and IC-2 cells at 0.01 to 100^g/ml but the supernatants from NATCdid not. These results demonstrate that CNG acts on CATCexclusively.
The effect of CNGon T cell functions was investigated in mice. After administration of CNGip to mice, splenic T cells were prepared and the incorporation of [3H]TdR into cultured cells and lymphokine activities of the culture supernatants were determined. As shown in Fig. 3 , the [3H]TdRincorporation into T cells increased on days 1 to 7 after administration and the culture supernatants prepared from T NOV. 1993 cell cultures enhanced the incorporation or [3H]TdR into CTLL-2 and IC-2 cells on days 1 and 5. A marked effect was observed on day 5 in both assays. These results indicate that CNGacts on T cells to stimulate incorporation of [3H]TdRand production of lymphokines in vitro and in vivo.
On the other hand, the culture supernatants of PECtreated with CNGat 0.1 to lOOjUg/ml and of PEC taken from mice given CNGdid not enhance the incorporation of [3H]TdR into D10.G4.1. cells. It should be noted that CNGwas not able to induce and to enhance monokine production by PECin vitro and in vivo.
Discussion
Most immunomodulators such as MDP1}, ubenimex2) and forphenicinol3 '4) are known to be activators for macrophages. It is obvious that afferent and/or efferent phases in the immunesystem are conducted by T lymphocytes. Thus, we have attempted to search for an immunomodulator which modulates T cell functions primarily. Accordingly, CATCwhich are activated with Con A have been employed for screening and CNGwas found in microbial products5). As shown above, CNGstimulated [3H]TdR incorporation into CATCbut did not stimulate NATC.The culture supernatants of CATCtreated with CNGalso stimulated [3H]TdR incorporation into lymphokine dependent cell lines, CTLL-2 and IC-2 cells. Although the identification and quantitation of lymphokines in the supernatants were not determined, it is considered that CNGenhances production of lymphokines such as IL-2, IL-3, IL-4 and GM-CSFby activated T cells, since CTLL-2 cells are used to assess murine T cell growth factor activity including IL-2 and IL-47'9) and IC-2 cells are used for hematopoietic cell growth factor assays including IL-3 and GM-CSF10).These effects of CNGwere also demonstrated in mice.
It will be reported that we investigated the binding activity of CNGto T cells treated with or without Con A and EL-4 thymoma cells and found that CNGonly bound to T cells activated by Con A or EL-4 cells but did not to non-activated T cells11}. The binding study suggests that the activated T cells may have a specific binding site for CNG.
It is reported that ubenimex also stimulates the proliferation of T cells2). However, ubenimex activates macrophages to induce production of . In this connection, CNGdid not activate peritoneal macrophages to produce monokine. We found that the administration of CNG reduces monokine production by peritoneal macrophages in tumor bearing mice13). Fromresults mentioned above, a low molecular immunomodulator CNGmaybe useful for cancer treatment and other immunological disorders.
